TY - JOUR
T1 - Cystic fibrosis
AU - Dickinson, Kimberly M.
AU - Collaco, Joseph M.
N1 - Publisher Copyright:
© 2021 American Academy of Pediatrics. All rights reserved.
PY - 2021/2/1
Y1 - 2021/2/1
N2 - Cystic fibrosis (CF) is one of the most commonly diagnosed genetic disorders. Clinical characteristics include progressive obstructive lung disease, sinusitis, exocrine pancreatic insufficiency leading to malabsorption and malnutrition, liver and pancreatic dysfunction, and male infertility. Although CF is a life-shortening disease, survival has continued to improve to a median age of 46.2 years due to earlier diagnosis through routine newborn screening, promulgation of evidence-based guidelines to optimize nutritional and pulmonary health, and the development of CF-specific interdisciplinary care centers. Future improvements in health and quality of life for individuals with CF are likely with the recent development of mutation-specific modulator therapies. In this review, we will cover the current understanding of the disease manifestations, diagnosis, and management as well as common complications seen in individuals with CF.
AB - Cystic fibrosis (CF) is one of the most commonly diagnosed genetic disorders. Clinical characteristics include progressive obstructive lung disease, sinusitis, exocrine pancreatic insufficiency leading to malabsorption and malnutrition, liver and pancreatic dysfunction, and male infertility. Although CF is a life-shortening disease, survival has continued to improve to a median age of 46.2 years due to earlier diagnosis through routine newborn screening, promulgation of evidence-based guidelines to optimize nutritional and pulmonary health, and the development of CF-specific interdisciplinary care centers. Future improvements in health and quality of life for individuals with CF are likely with the recent development of mutation-specific modulator therapies. In this review, we will cover the current understanding of the disease manifestations, diagnosis, and management as well as common complications seen in individuals with CF.
UR - http://www.scopus.com/inward/record.url?scp=85100500028&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85100500028&partnerID=8YFLogxK
U2 - 10.1542/pir.2019-0212
DO - 10.1542/pir.2019-0212
M3 - Article
C2 - 33526571
AN - SCOPUS:85100500028
SN - 0191-9601
VL - 42
SP - 55
EP - 65
JO - Pediatrics in Review
JF - Pediatrics in Review
IS - 2
ER -